Tumour immunology: T cells work together to fight cancer

Current Biology

Volumn 9, Issue 18, 1999, Pages

  Cerundolo, Vincenzo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HLA ANTIGEN CLASS 2; TUMOR ANTIGEN;

ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; IMMUNOSURVEILLANCE; MELANOMA; MOUSE; NEOPLASM; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC SURVEILLANCE; MELANOMA; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0033598216     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(99)80442-4     Document Type: Article

References (16)

1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den Eynde B, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254:1643-1647.
2. Cox A, Skipper J, Chen Y, Henderson R, Darrow T, Shabanowitz J, Engelhard V, Hunt D, Slingluff C: Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994, 264:716-719.
3. Old LI, Chen YT: New paths in human cancer serology. J Exp Med 1998, 187:1163-1167.
4. Wang R-F, Wang X, Atwood AC, Topalian S, Rosenberg SA: Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen. Science 1999, 284:1351-1354.
5. + T cells. J Exp Med 1999, 189:1659-1668.
6. + T lymphocytes. J Exp Med 1999, 189:767-777.
7. + cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med 1999, 189:871-876.
8. + T cells. J Exp Med 1999, 189:757-765.
9. + T lymphocytes. Proc Natl Acad Sci USA 1999, 96:2982-2987.
10. Ossendorp F, Mengede E, Camps M, Filius R, Melief C: Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumours. J Exp Med 1998, 187:693-702.
11. Lanzavecchia A: Licence to kill. Nature 1998, 393:413-414.
12. + T cells in the antitumor immune response. J Exp Med 1998, 188:2357-2368.
13. Huang AY, Golumbeck M, Ahmadzadeh M, Jaffe E, Pardoll D, Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994, 264:961-965.
14. Nuchtern JG, Biddison WE, Klausner RD: Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990, 343:74-76.
15. Cuervo AM, Dice JF: A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996, 273:501-503.
16. Romero P, Dunbar PR, Valmori D, Pittet M, OGG G, Rimoldi D, Chen J-L, Lienard D, Cerottini J-C, Cerundolo V: Ex-vivo staining of metastatic lymph nodes by class I MHC tetramers reveals high numbers of antigen-experienced tumour specific CTL J Exp Med 1998, 188:1641-1650.